Injective (INJ) is currently trading at $2.81, reflecting a 1.38% increase over the last 24 hours. The price has experienced a daily range of $0.09, with a high of $2.82 and a low of $2.73, indicating relatively stable trading conditions.

The trading volume over the past 24 hours stands at approximately 47.6 million, representing 16.97% of the market cap, which suggests a healthy level of market activity. However, the 7-day and 14-day price changes show declines of 5.38% and 12.93%, respectively, indicating bearish pressure over these time frames.

Examining the moving averages reveals mixed signals; the 8 SMA ($2.75), 13 SMA ($2.76), and 21 SMA ($2.77) all exhibit positive momentum, while the 55 SMA ($2.85) and 144 SMA ($2.86) show negative trends. The current hourly RSI at 55 indicates neutral momentum, whereas the 7-day RSI at 49 suggests that INJ is nearing oversold conditions.

Despite the recent downward trend over the longer time frames, the short-term momentum reflected in the moving averages and the positive daily change may indicate a potential for recovery. The substantial gap to its all-time high of $52.62 suggests significant room for growth if market conditions shift positively.

Considering the current technical indicators and recent price action, the recommendation is to Hold INJ. This stance allows for observing potential bullish signals from the moving averages while avoiding premature investment in a market still exhibiting bearish tendencies over the longer term.